The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery

BACKGROUND: High soluble suppression of tumorigenicity-2 (sST2) is a marker of poor prognosis in chronic inflammatory conditions. ST2 and its ligand interleukin (IL)-33 are elevated in adipose tissue of obese individuals. We aimed to evaluate circulating sST2 and IL-33 as possible markers of metabol...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cardiovasc Diabetol
Autors principals: Demyanets, Svitlana, Kaun, Christoph, Kaider, Alexandra, Speidl, Walter, Prager, Manfred, Oravec, Stanislav, Hohensinner, Philipp, Wojta, Johann, Rega-Kaun, Gersina
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7045735/
https://ncbi.nlm.nih.gov/pubmed/32101157
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-020-01001-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars